Alzheimer Disease Drug Market Pipeline Drugs Review Research Report and Forecasts to 2018 - PowerPoint PPT Presentation

View by Category
About This Presentation
Title:

Alzheimer Disease Drug Market Pipeline Drugs Review Research Report and Forecasts to 2018

Description:

Alzheimer’s disease drug market is on the curvature stage. Since 2003, there is not any single “magic bullet” launched in the market to prevent or cure it. However, all current marketed products are going to be generic in the next 3-4 years. There are high unmet medical needs. The current unmet needs represent a huge opportunity for pharmaceutical companies which are developing targeted novel therapies. – PowerPoint PPT presentation

Number of Views:109

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Alzheimer Disease Drug Market Pipeline Drugs Review Research Report and Forecasts to 2018


1
Alzheimers Pipeline Drugs Review, Alzheimers
Disease Drug Market Forecast Global
AnalysisbyRenub Research
Published Dec 2013 No of Pages 110 Single
User PDF US 1475 Corporate User PDF US 2100
  • View Complete Report _at_ http//www.lifescienceindus
    tryresearch.com/alzheimers-pipeline-drugs-review-a
    lzheimers-disease-drug-market-forecast-global-anal
    ysis.html .

2
Alzheimers Pipeline Drugs Review, Alzheimers
Disease Drug Market Forecast Global Analysis
Alzheimers disease drug market is on the
curvature stage. Since 2003, there is not any
single magic bullet launched in the market to
prevent or cure it. However, all current marketed
products are going to be generic in the next 3-4
years. There are high unmet medical needs. The
current unmet needs represent a huge opportunity
for pharmaceutical companies which are developing
targeted novel therapies. If successful, they
will be in a position to command premium prices
and tap the existing opportunity. Lot of drugs
has failed in Phase III stage thus putting a
greater impact on Alzheimers disease drug
market. From the year 2009 Alzheimers disease
drug market is declining and it is expected to
fall till 2016. But with the expected launch of
some Alzheimers drugs from the year 2017
onwards, Alzheimers disease drug market is
expected to revive in the coming years. However
due to absence of exact potential drugs there
will always remain a huge Unmet Alzheimers Drug
Market. For the year 2018 Alzheimers Disease
Drug Market will be just 10 of Unmet Alzheimers
Disease Drug Market. Alzheimers Pipeline Drugs
Review, Alzheimers Disease Drug Market
Forecast Global Analysis provides a
comprehensive assessment of the fast-evolving,
high-growth Global Alzheimers Disease Market.
This 110 page report with 29 Figures and 11
Tables studies the Global Alzheimers Disease
Drug Market.
Buy a Copy of this Report _at_ http//www.lifescience
industryresearch.com/purchase?rname8972 .
3
Alzheimers Pipeline Drugs Review, Alzheimers
Disease Drug Market Forecast Global Analysis
Present Pipeline Drugs Studied in this
Report 1. Namenda2. Ebixa3. Axura4. Aricept5.
Nootropil6. Exelon7. Memary8. Solanezumab9.
LuAe58054 This report contains 10
chapters. (Chapter 1) Executive Summary (Chapter
2) This Chapter is divided into 2 parts A.
Alzheimers Disease Drug Market Forecast data
available from 2003 to 2018B. Unmet Alzheimers
Disease Drug Market Forecast (Market Potential)
data available from 2010 to 2018. (Unmet market
is the potential market which could have been
achieved if right drug have been introduced in
the market) (Chapter 3) This chapter talks about
drugs which has failed while in Clinical
trials (Chapter 4) This chapter provides Market
Share of Alzheimers Disease Drug from 2003 to
2018. All the 9 Alzheimers drug mentioned above
have been covered in this chapter.
4
Alzheimers Pipeline Drugs Review, Alzheimers
Disease Drug Market Forecast Global Analysis
(Chapter 5) This chapter talks about Alzheimers
Drugs performance. All important drugs mentioned
above past, present future market data
available from 2003 to 2018. (Chapter 6)
Pipeline drugs (Solanezumab, LuAE58054,
Gantenerumab, Crenezumab, TRx0237 (LMTX),
MK-8931, ABT-126, AZD-1446) have been analyzed in
this chapter. All drugs have been analyzed from 5
view points A. Clinical Development StageB.
Pipeline Drug Sales PerformanceC. Recent
Clinical DevelopmentD. Different Companies
DealE. Investment (Chapter 7) This chapter
speaks of Alzheimers Drugs Company deals in four
areas A. Strategic Alliances in Alzheimers
Disease Drug MarketB. Licensing Agreement in
Alzheimers Disease Drug MarketC. Collaboration
Deal in Alzheimers Disease Drug MarketD. Merger
Acquisition in Alzheimers Disease Drug
Market (Chapter 8) This chapter studies Funding
in Alzheimers Disease Drugs Research. We have
covered 5 institutes which provides fund for the
research. A. National Institute of HealthB.
Alzheimers AssociationC. Cure Alzheimers
FundD. Alzheimers Drug Discovery FoundationE.
Bright Focus Foundation formerly American Health
Assistance Foundation (AHAF)
Inquire Before Buying this report _at_
http//www.lifescienceindustryresearch.com/inquire
-before-buying?rname8972 .
5
Alzheimers Pipeline Drugs Review, Alzheimers
Disease Drug Market Forecast Global Analysis
(Chapter 9) This chapter studies Growth Factors
Driving the Alzheimers Disease Drug
Market. (Chapter 10) This chapter studies
Challenges/Hindrances faced by Alzheimers
Disease Drug Market. Data Sources This report
is built using data and information sourced from
proprietary databases, primary and secondary
research and in-house analysis by Renub Research
team of industry experts. Primary sources
include industry surveys and telephone interviews
with industry experts. Secondary sources
information and data has been collected from
various printable and non-printable sources like
search engines, News websites, Government
Websites, Trade Journals, White papers,
Government Agencies, Magazines, Newspapers, Trade
associations, Books, Industry Portals, Industry
Associations and access to more than 500 paid
databases.
6
Alzheimers Pipeline Drugs Review, Alzheimers
Disease Drug Market Forecast Global Analysis
Table of Contents 1. Executive Summary2.
Worldwide - Alzheimer's Disease Drug Market
Analysis2.1 Alzheimer Disease Drug Market
Forecast2.2 Unmet Alzheimer's Disease Drug
Market Forecast (Market Potential) 3. Failed
Alzheimer's Drugs3.1 Dismal Results but Still
Trying Again 4. Worldwide - Alzheimer's Disease
Drug Market Share Forecast 5. Worldwide -
Alzheimer's Drug Brands Market Performance5.1
Exelon (Rivastigmine) - Past, Present Future
Market5.2 Aricept (Donepezil) - Past, Present
Future Market5.3 Memantine (Namenda, Ebixa,
Axura, Memary) Past, Present Future
Market5.3.1 Namenda (Memantine) - Past, Present
Future Market5.3.2 Ebixa (Memantine) - Past,
Present Future Market5.3.3 Axura (Memantine) -
Past, Present Future Market5.3.4 Memary
(Memantine) - Past, Present Future Market5.4
Nootropil (Piracetam) - Past, Present Future
Market
7
About us Life Science Industry
Research brings to you to the latest reports in
market research on Biotechnology, Diagnostics,
Healthcare, Medical Devices and Pharmaceuticals
segments from leading research publishers across
the globe. These reports also cover data and
information on sub-segments and sectors under
these life sciences categories.Contact us
(sales_at_lifescienceindustryresearch.com / 1 888
391 5441) for any of your research requirements
or topics of interest. Our sales research
associates will be happy to help you find
relevant market data.Website
www.lifescienceindustryresearch.com
Browse Latest Industry News, Updates, Trends,
Opportunities, Scenario all over the world _at_
About PowerShow.com